Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive phase II results for Hycamtin in small cell lung cancer

May 7, 1997

New antitumor agents from Banyu

May 7, 1997

Chiron and DepoTech complete NDA for DepoCyt

May 6, 1997

Cyclic hexapeptide antitumor agents described by Taisho

May 6, 1997

Pharma Mar isolates new cytotoxic agents from marine sponge

May 6, 1997

OXiGENE initiates U.S. preclinical and clinical research

May 2, 1997

Targeted Genetics' E1A tumor suppressor gene product progresses in clinical trials

May 2, 1997

Natural compounds that inhibit oncogene function from Terumo

May 2, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

NCI identifies compounds effective against aggressive human tumors

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...